Z-0210-2020Class II
Beckman Coulter Lipase, REF OSR6130 and OSR6230
Siemens Healthcare Diagnostics Inc. / initiated 2018-08-24 / Terminated / root cause: manufacturing process
Beckman Coulter Inc. began a recall of Beckman Coulter Lipase, REF OSR6130 and OSR6230 on . FDA classified it as Class II and gives the reason as "NAPQI, a metabolite of Acetaminophen, causes negative interference with the recalled product assays at levels present in the serum/plasma of overdose patients". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.
Recall record
- Recall number
- Z-0210-2020
- Classification
- Class II
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Siemens Healthcare Diagnostics Inc.
- Product
- Beckman Coulter Lipase, REF OSR6130 and OSR6230.
- Product code
- CDT Lipase Hydrolysis/Glycerol Kinase Enzyme, Triglycerides
- Reason for recall
- NAPQI, a metabolite of Acetaminophen, causes negative interference with the recalled product assays at levels present in the serum/plasma of overdose patients.
- Root cause tag
- manufacturing process
- FDA root cause
- Nonconforming Material/Component
- Action
- The recalling firm issued letters dated 8/21/2018 via email or postal mail if an email address was not available on 8/24/2018 to their customers. The letter identified the affected product, problem and actions to be taken. For questions call 1-800-223-0139 in the United States and Canada. Outside the United States and Canada contact local Beckman Coulter Representative.
- Quantity in commerce
- 20,926 units
- Distribution
- Distribution was nationwide. There was government and military distribution. Foreign distribution was made to Canada.
- Product codes and lots
- All lots
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-0210-2020 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-0211-2020 | Class II | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
